The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Official Title: Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Study ID: NCT00575744
Brief Summary: We continue to collect information in support of the hypothesis that the histology of the first draining lymph node (sentinel node) accurately predicts the histology of the rest of the axillary lymph nodes.
Detailed Description: Using a technique combining Technetium-99 sulfur colloid and Lymphazurin Blue Dye, we have established that the sentinel node predicts the pathology results of the rest of the axillary lymph nodes. This minimally invasive technique, which can be readily performed under local anesthesia, makes the need for full axillary lymph node dissection unnecessary for most patients. If the sentinel node is negative, no further surgery is necessary. If positive, a complete axillary node dissection is performed. In addition, the injections are made while the patient is under anesthesia, reducing the physical and psychological pain that accompanies injections done pre-operatively.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States
Name: V. Suzanne Klimberg, MD
Affiliation: University of Arkansas
Role: PRINCIPAL_INVESTIGATOR